Hereditary angioedema (HAE) in children and adolescents--a consensus on therapeutic strategies

European Journal of Pediatrics, 05/17/2012

Currently, plasma–derived C1 inhibitor concentrate is considered the best available option for the treatment of acute HAE–C1–INH attacks in pediatric patients in German–speaking countries, as well as for short–term and long–term prophylaxis.

Print Article Summary Cat 2 CME Report